Jerome Ritz
Hematology · Boston, MANPI 1407824659
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,560 of the $3,589 with a category attached, or 99.2%. Bristol Myers Squibb accounts for 99.2% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hematology clinicians in MA, where the typical reported total is $3,500.
Across 3 payments — averaging $1196.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$4K
- Regeneron$29
Across 15 payments — averaging $134,198 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$923K
- Vertex$809K
- Amgen$260K
- Iovance Biotherapeutics, Inc.$10K
- Clinigen, Inc.$10K
- Novartis$1K
What the payments were for
- Consulting fees$3,56099%
- Food & beverage$291%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 2 | $3,560 |
| Regeneron | 1 | $29 |
How this compares
$3,589 in reported general payments places this provider in the 50th percentile of 77 hematology providers in Massachusetts.
Other hematology in Boston
- Edward BenzBoston$747K
- David KuterBoston$543K
- Jacalyn RosenblattBoston$455K
- Lynn BryBoston$286K
- John SloanBoston$257K
- Andrew EvensBoston$217K
- Omar NadeemBoston$191K
- Nathan ConnellBoston$145K
- Jean ConnorsBoston$144K
- Heather BenjaminBoston$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.